Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Treatment schedule

YW Yuan Wang
GH Guo-fang Hu
ZW Zhe-hai Wang
ask Ask a question
Favorite

The chemotherapy regimens were used according to the histological types. Treatment schedules consisted of at least two cycles of pemetrexed (500 mg/m2) combined with cisplatin (75 mg/m2) or carboplatin (AUC =5–6) or nedaplatin (80 mg/m2) or lobaplatin (50 mg/m2); docetaxel (75 mg/m2) combined with cisplatin or carboplatin or nedaplatin; gemcitabine (1,250 mg/m2) combined with cisplatin or carboplatin or nedaplatin or lobaplatin; and etoposide (100 mg/m2) combined with cisplatin. Among them, some patients with lung adenocarcinoma were administered with bevacizumab (15 mg/kg) combined with chemotherapy agents.

Copyright and License information:  ©2017 Wang et al. This work is published and licensed by Dove Medical Press Limited
The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A